Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Hidetoshi Arima
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Living Beings
Physiology
Devices
Phenomena
Anatomy
Sign-in to see full Profile
Network (preview)
61
Uekama, Kaneto
58
Hirayama, Fumitoshi
15
Irie, Tetsumi
10
Motoyama, Keiichi
6
Yano, Hideki
6
Tsutsumi, Toshihito
4
Yunomae, Kiyokazu
4
Miyake, K
3
Misumi, Shogo
3
Nagase, Yukihiko
3
Ono, N
3
Kihara, Fumihiro
3
Wada, Koki
3
Nishimoto, Yoji
3
Tajiri, Shinichiro
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Hidetoshi Arima (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Motoyama Keiichi; Nagatomo Kiyoshi; Abd Elazim Soliman Osama; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Chemical & pharmaceutical bulletin 2009;57(11):1206-12.
-
2009: Motoyama Keiichi; Kameyama Kazuhisa; Onodera Risako; Araki Norie; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;38(3):249-61.
-
2009: Higashi Taishi; Nishimura Katsunori; Yoshimatsu Ayumi; Ikeda Haruna; Arima Kanako; Motoyama Keiichi; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Preparation of four types of coenzyme Q10/gamma-cyclodextrin supramolecular complexes and comparison of their pharmaceutical properties.
Chemical & pharmaceutical bulletin 2009;57(9):965-70.
-
2009: Higashi Taishi; Hirayama Fumitoshi; Yamashita Shogo; Misumi Shogo; Arima Hidetoshi; Uekama Kaneto
Slow-release system of pegylated lysozyme utilizing formation of polypseudorotaxanes with cyclodextrins.
International journal of pharmaceutics 2009;374(1-2):26-32.
-
2009: Higashi Taishi; Hirayama Fumitoshi; Misumi Shogo; Motoyama Keiichi; Arima Hidetoshi; Uekama Kaneto
Polypseudorotaxane formation of randomly-pegylated insulin with cyclodextrins: slow release and resistance to enzymatic degradation.
Chemical & pharmaceutical bulletin 2009;57(5):541-4.
-
2009: Motoyama Keiichi; Toyodome Hiroshi; Onodera Risako; Irie Tetsumi; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated beta-cyclodextrins.
Biological & pharmaceutical bulletin 2009;32(4):700-5.
-
2009: Motoyama Keiichi; Hashimoto Yosuke; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Inhibitory effects of 2,6-di-O-methyl-alpha-cyclodextrin on poly I:C signaling in macrophages.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2009;36(2-3):285-91.
-
2008: Higashi Taishi; Hirayama Fumitoshi; Misumi Shogo; Arima Hidetoshi; Uekama Kaneto
Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system.
Biomaterials 2008;29(28):3866-71.
-
2008: Tsutsumi Toshihito; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
Journal of pharmaceutical sciences 2008;97(8):3022-34.
-
2008: Nishimura Katsunori; Higashi Taishi; Yoshimatsu Ayumi; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Pseudorotaxane-like supramolecular complex of coenzyme Q10 with gamma-cyclodextrin formed by solubility method.
Chemical & pharmaceutical bulletin 2008;56(5):701-6.
-
2008: Takeo Toru; Hoshii Takayuki; Kondo Yuki; Toyodome Hiroshi; Arima Hidetoshi; Yamamura Ken-ichi; Irie Tetsumi; Nakagata Naomi
Methyl-beta-cyclodextrin improves fertilizing ability of C57BL/6 mouse sperm after freezing and thawing by facilitating cholesterol efflux from the cells.
Biology of reproduction 2008;78(3):546-51.
-
2007: Tsutsumi Toshihito; Hirayama Fumitoshi; Uekama Kaneto; Arima Hidetoshi
Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Journal of controlled release : official journal of the Controlled Release Society 2007;119(3):349-59.
-
2007: Higashi Taishi; Hirayama Fumitoshi; Arima Hidetoshi; Uekama Kaneto
Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release system.
Bioorganic & medicinal chemistry letters 2007;17(7):1871-4.
-
2006: Tavornvipas Sumitra; Hirayama Fumitoshi; Takeda Seiko; Arima Hidetoshi; Uekama Kaneto
Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor.
Journal of pharmaceutical sciences 2006;95(12):2722-9.
-
2006: Arima Hidetoshi; Chihara Yuko; Arizono Masayo; Yamashita Shogo; Wada Koki; Hirayama Fumitoshi; Uekama Kaneto
Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
Journal of controlled release : official journal of the Controlled Release Society 2006;116(1):64-74.
-
2006: Motoyama Keiichi; Arima Hidetoshi; Toyodome Hiroshi; Irie Tetsumi; Hirayama Fumitoshi; Uekama Kaneto
Effect of 2,6-di-O-methyl-alpha-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;29(2):111-9.
-
2006: Hara Takumi; Arima Hidetoshi; Hirayama Fumitoshi; Uekama Kaneto
Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated rats.
Journal of pharmaceutical sciences 2006;95(8):1771-82.
-
2006: Arima Hidetoshi; Hagiwara Yoshiyuki; Hirayama Fumitoshi; Uekama Kaneto
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.
Journal of drug targeting 2006;14(4):225-32.
-
2006: Hara Takumi; Hirayama Fumitoshi; Arima Hidetoshi; Yamaguchi Yoshihiro; Uekama Kaneto
Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Chemical & pharmaceutical bulletin 2006;54(3):344-9.
-
2006: Sonoda Yoh; Hirayama Fumitoshi; Arima Hidetoshi; Yamaguchi Yoshihiro; Saenger Wolfram; Uekama Kaneto
Cyclodextrin-based isolation of Ostwald's metastable polymorphs occurring during crystallization.
Chemical communications (Cambridge, England) 2006;(5):517-9.
-
2006: Hagiwara Yoshiyuki; Arima Hidetoshi; Miyamoto Yuji; Hirayama Fumitoshi; Uekama Kaneto
Preparation and pharmaceutical evaluation of liposomes entrapping salicylic acid/gamma-cyclodextrin conjugate.
Chemical & pharmaceutical bulletin 2006;54(1):26-32.
-
2005: Shuto Tsuyoshi; Kato Kosuke; Mori Yoko; Viriyakosol Suganya; Oba Mariko; Furuta Takashi; Okiyoneda Tsukasa; Arima Hidetoshi; Suico Mary Ann; Kai Hirofumi
Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
Biochemical and biophysical research communications 2005;338(3):1402-9.
-
2005: Arima Hidetoshi; Motoyama Keiichi; Matsukawa Akihiro; Nishimoto Yoji; Hirayama Fumitoshi; Uekama Kaneto
Inhibitory effects of dimethylacetyl-beta-cyclodextrin on lipopolysaccharide-induced macrophage activation and endotoxin shock in mice.
Biochemical pharmacology 2005;70(10):1506-17.
-
2005: Wada Koki; Arima Hidetoshi; Tsutsumi Toshihito; Chihara Yuko; Hattori Kenjiro; Hirayama Fumitoshi; Uekama Kaneto
Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates.
Journal of controlled release : official journal of the Controlled Release Society 2005;104(2):397-413.
-
2005: Motoyama Keiichi; Arima Hidetoshi; Nishimoto Yoji; Miyake Kensuke; Hirayama Fumitoshi; Uekama Kaneto
Involvement of CD14 in the inhibitory effects of dimethyl-alpha-cyclodextrin on lipopolysaccharide signaling in macrophages.
FEBS letters 2005;579(7):1707-14.
-
2005: Wada Koki; Arima Hidetoshi; Tsutsumi Toshihito; Hirayama Fumitoshi; Uekama Kaneto
Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency.
Biological & pharmaceutical bulletin 2005;28(3):500-5.
-
2004: Tavornvipas Sumitra; Tajiri Shinichiro; Hirayama Fumitoshi; Arima Hidetoshi; Uekama Kaneto
Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone.
Pharmaceutical research 2004;21(12):2369-76.
-
2004: Arima Hidetoshi
[Polyfection as nonviral gene transfer method -design of novel nonviral vector using alpha-cyclodextrin]
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2004;124(7):451-64.
-
2004: Arima Hidetoshi; Yunomae Kiyokazu; Morikawa Tadatoshi; Hirayama Fumitoshi; Uekama Kaneto
Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.
Pharmaceutical research 2004;21(4):625-34.
-
2003: Nagase Yukihiko; Arima Hidetoshi; Wada Koki; Sugawara Tadaki; Satoh Hiroshi; Hirayama Fumitoshi; Uekama Kaneto
Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
Journal of pharmaceutical sciences 2003;92(12):2466-74.
-
2003: Kihara Fumihiro; Arima Hidetoshi; Tsutsumi Toshihito; Hirayama Fumitoshi; Uekama Kaneto
In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
Bioconjugate chemistry 2003;14(2):342-50.
-
2003: Yunomae Kiyokazu; Arima Hidetoshi; Hirayama Fumitoshi; Uekama Kaneto
Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells.
FEBS letters 2003;536(1-3):225-31.
-
2002: Tavornvipas Sumitra; Hirayama Fumitoshi; Arima Hidetoshi; Uekama Kaneto; Ishiguro Toshihiro; Oka Masahide; Hamayasu Kenichi; Hashimoto Hitoshi
6-O-alpha-(4-O-alpha-D-glucuronyl)-D-glucosyl-beta-cyclodextrin: solubilizing ability and some cellular effects.
International journal of pharmaceutics 2002;249(1-2):199-209.
-
2002: Kihara Fumihiro; Arima Hidetoshi; Tsutsumi Toshihito; Hirayama Fumitoshi; Uekama Kaneto
Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
Bioconjugate chemistry 2002;13(6):1211-9.
-
2002: Nagase Y; Hirata M; Arima H; Tajiri S; Nishimoto Y; Hirayama F; Irie T; Uekama K
Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
Journal of pharmaceutical sciences 2002;91(11):2382-9.
-
2002: Kamada Makoto; Hirayama Fumitoshi; Udo Koichi; Yano Hideki; Arima Hidetoshi; Uekama Kaneto
Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats.
Journal of controlled release : official journal of the Controlled Release Society 2002;82(2-3):407-16.
-
2002: Yano Hideki; Hirayama Fumitoshi; Kamada Makoto; Arima Hidetoshi; Uekama Kaneto
Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):103-12.
-
2001: Yano H; Hirayama F; Arima H; Uekama K
Prednisolone-appended alpha-cyclodextrin: alleviation of systemic adverse effect of prednisolone after intracolonic administration in 2,4,6-trinitrobenzenesulfonic acid-induced colitis rats.
Journal of pharmaceutical sciences 2001;90(12):2103-12.
-
2001: Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
Pharmaceutical research 2001;18(11):1578-85.
-
2001: Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
International journal of pharmaceutics 2001;229(1-2):163-72.
-
2001: Arima H; Nishimoto Y; Motoyama K; Hirayama F; Uekama K
Inhibitory effects of novel hydrophilic cyclodextrin derivatives on nitric oxide production in macrophages stimulated with lipopolysaccharide.
Pharmaceutical research 2001;18(8):1167-73.
-
2001: Arima H; Kihara F; Hirayama F; Uekama K
Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins.
Bioconjugate chemistry 2001;12(4):476-84.
-
2001: Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
Journal of pharmaceutical sciences 2001;90(6):690-701.
-
2001: Arima H; Yunomae K; Hirayama F; Uekama K
Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
The Journal of pharmacology and experimental therapeutics 2001;297(2):547-55.
-
2001: Ono N; Arima H; Hirayama F; Uekama K
A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin.
Biological & pharmaceutical bulletin 2001;24(4):395-402.
-
2001: Yano H; Hirayama F; Arima H; Uekama K
Preparation of prednisolone-appended alpha-, beta- and gamma-cyclodextrins: substitution at secondary hydroxyl groups and in vitro hydrolysis behavior.
Journal of pharmaceutical sciences 2001;90(4):493-503.
-
2001: Ono N; Hirayama F; Arima H; Uekama K
Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation.
Chemical & pharmaceutical bulletin 2001;49(1):78-81.
-
2000: Hirayama F; Ogata T; Yano H; Arima H; Udo K; Takano M; Uekama K
Release characteristics of a short-chain fatty acid, n-butyric acid, from its beta-cyclodextrin ester conjugate in rat biological media.
Journal of pharmaceutical sciences 2000;89(11):1486-95.
-
2000: Tokihiro K; Arima H; Tajiri S; Irie T; Hirayama F; Uekama K
Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.
The Journal of pharmacy and pharmacology 2000;52(8):911-7.
-
2000: Yano H; Hirayama F; Arima H; Uekama K
Hydrolysis behavior of prednisolone 21-hemisuccinate/beta-cyclodextrin amide conjugate: involvement of intramolecular catalysis of amide group in drug release.
Chemical & pharmaceutical bulletin 2000;48(8):1125-8.
-
2000: Hirayama F; Honjo M; Arima H; Okimoto K; Uekama K
X-ray crystallographic characterization of nilvadipine monohydrate and its phase transition behavior.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2000;11(1):81-8.
-
2000: Kimura K; Hirayama F; Arima H; Uekama K
Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Chemical & pharmaceutical bulletin 2000;48(5):646-50.
-
2000: Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Pharmaceutical development and technology 2000;5(3):399-407.
-
1999: Kimura K; Hirayama F; Arima H; Uekama K
Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
Pharmaceutical research 1999;16(11):1729-34.
-
1999: Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
Journal of pharmaceutical sciences 1999;88(10):970-5.
-
1999: Ono N; Hirayama F; Arima H; Uekama K
Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;8(2):133-9.
-
1999: Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
International journal of pharmaceutics 1999;179(2):237-45.
-
1999: Miyake K; Arima H; Irie T; Hirayama F; Uekama K
Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
Biological & pharmaceutical bulletin 1999;22(1):66-72.
-
1998: Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1998;6(1):53-9.
-
1996: Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
Chemical & pharmaceutical bulletin 1996;44(3):582-6.
-
1992: Arima H; Kondo T; Irie T; Uekama K
Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
Journal of pharmaceutical sciences 1992;81(11):1119-25.
-
1992: Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y
[Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery]
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 1992;112(1):65-72.
-
1990: Arima H; Adachi H; Irie T; Uekama K; Pitha J
Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
Pharmaceutical research 1990;7(11):1152-6.
-
1989: Uekama K; Arima H; Irie T; Matsubara K; Kuriki T
Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin.
The Journal of pharmacy and pharmacology 1989;41(12):874-6.
Sign-in to see more
